Quest PharmaTech Ratios and Metrics

Market cap in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 10, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Market Cap	5	7	7	5	12	15
Market Cap Growth	20.00%	-	33.33%	-57.14%	-21.81%	-55.00%
Enterprise Value	6.06	7.75	7.56	5.36	12.46	15.38
Last Close Price	0.03	0.04	0.04	0.03	0.07	0.09
PE Ratio	1.02	1.33	-	-	-	-
PB Ratio	0.19	0.26	0.32	0.22	0.46	0.17
P/TBV Ratio	0.19	0.26	0.32	0.22	0.46	0.17
Debt / Equity Ratio	0.04	0.04	0.05	0.04	0.04	0.01
Net Debt / Equity Ratio	0.04	0.04	0.04	0.01	0.02	0.00
Net Debt / EBITDA Ratio	-1.39	-1.39	-0.97	-0.22	-0.76	-0.33
Net Debt / FCF Ratio	-5.17	-5.17	-1.55	-0.83	-1.13	-1.46
Quick Ratio	0.01	0.01	0.18	0.62	0.54	0.43
Current Ratio	0.02	0.02	0.19	0.63	0.56	0.46
Return on Equity (ROE)	20.19%	20.90%	-8.09%	-12.36%	-111.78%	-64.03%
Return on Assets (ROA)	-2.73%	-2.83%	-3.47%	-5.13%	-1.42%	-0.59%
Return on Invested Capital (ROIC)	-2.64%	-2.73%	-3.41%	-5.08%	-1.41%	-0.59%
Return on Capital Employed (ROCE)	-2.87%	-2.97%	-3.67%	-5.39%	-1.44%	-0.60%
Earnings Yield	98.51%	75.00%	-	-	-	-
Buyback Yield / Dilution	-	0.00%	0.00%	-0.44%	-0.09%	-0.27%
Total Shareholder Return	-	0.00%	0.00%	-0.44%	-0.09%	-0.27%